Melisron names an acting CEO: what it means for Melisron stock

Published on 10/13/2026 at 10:36 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWS

Oren Hilinger became acting CEO after Ophir Sarid died at 54. Melisron stock stood at ILA 38,060 on October 13, 2026, below its ILA 47,900 high.

Melisron named Oren Hilinger acting CEO after Ophir Sarid died at age 54.
Second-quarter NOI reached ILS 412 million and shopping mall sales rose 11 percent.
Melisron stock stood at ILA 38,060 on October 13, 2026, 20.54 percent below its ILA 47,900 yearly high.
The next earnings report is scheduled for November 25, 2026.

Melisron, IL0003230146, Illustration mit AI erstellt.

Melisron (ISIN IL0003230146) named Chief Financial Officer Oren Hilinger acting CEO after Chief Executive Officer Ophir Sarid died at age 54 on September 28, 2026. As CTech reported on September 28, 2026, Hilinger will lead the company while Melisron searches for a permanent successor.

Three events shape the transition

On August 13, 2026, Melisron reported second-quarter net income of ILS 289.0 million and declared an ILS 90.0 million dividend, according to Melisron. The same reporting update said net operating income reached ILS 412.0 million and shopping mall sales increased 11.00 percent.

On September 2, 2026, Sarid began medical leave at age 54, according to Zonebourse. On September 28, 2026, his death brought the leadership transition to its current stage, with Hilinger serving as acting CEO.

What does the transition mean for operations?

Melisron's operating base remains large: the company owns 29 rental properties, manages 1,067,000 square meters and reported average occupancy of 97.80 percent as of June 30, 2026, according to Melisron. Regional malls represent 68.00 percent of its operational mix, while offices and high-tech parks account for 27.00 percent.

The latest quarterly figures show the scale of the business behind the management change. Revenue reached ILS 588.0 million in the second quarter of 2026, versus ILS 580.0 million in the first quarter, while net income rose from ILS 265.0 million to ILS 289.0 million.

Next report comes on November 25

TradingView lists November 25, 2026, as Melisron's next earnings date. The figure gives investors a defined checkpoint for assessing the leadership transition against second-quarter revenue of ILS 588.0 million and net income of ILS 289.0 million.

Stock remains below its yearly high

Melisron stock stood at ILA 38,060 on the Tel Aviv Stock Exchange on October 13, 2026 at 11:19 a.m. IDT. The price was ILA 9,840 below the ILA 47,900 52-week high, a gap of 20.54 percent, while market capitalization was ILS 18.2 billion.